{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:28:11Z","timestamp":1763036891907},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","publichealthjrnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.puhe.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T20:28:05Z","timestamp":1429216085000},"page":"763-768","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Surveillance of adverse events following vaccination in the French armed forces, 2011\u20132012"],"prefix":"10.1016","volume":"129","author":[{"given":"A.","family":"Mayet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Duron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Meynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Koeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Deparis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Migliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2015.03.003_bib1","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.24.20193-en","article-title":"Adverse events following vaccination in the french armed forces: an overview of surveillance conducted from 2002 to 2010","volume":"17","author":"Mayet","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.puhe.2015.03.003_bib2","first-page":"1","article-title":"Surveillance for safety after immunization: VAE reporting system (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.puhe.2015.03.003_bib3","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow Fever Vaccine Safety Working Group. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2015.03.003_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jinf.2012.11.012","article-title":"The measles outbreak in the French military forces \u2013 2010\u20132011: results of epidemiological surveillance","volume":"66","author":"Mayet","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.puhe.2015.03.003_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.respe.2013.11.075","article-title":"Feedback on the management of the 2011 measles outbreak by French military general practitioners: an evaluation study","volume":"62","author":"G\u00e9nicon","year":"2014","journal-title":"Rev \u00c9pid\u00e9miol Sant\u00e9 Publ"},{"key":"10.1016\/j.puhe.2015.03.003_bib6","first-page":"416","article-title":"Organization and results of drug vigilance in France","volume":"42","author":"Begaud","year":"1994","journal-title":"Rev \u00c9pid\u00e9miol Sante Publ"},{"key":"10.1016\/j.puhe.2015.03.003_bib7","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.vaccine.2011.01.056","article-title":"Adverse events following pandemic influenza vaccine Pandemrix\u00ae reported in the French military forces \u2013 2009\u20132010","volume":"29","author":"Mayet","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2015.03.003_bib8","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs","volume":"vol. 6","author":"Weber","year":"1984"},{"key":"10.1016\/j.puhe.2015.03.003_bib9","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus\u2013diphtheria\u2013acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2015.03.003_bib10","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.vaccine.2009.05.036","article-title":"An assessment of the safety of adolescent and adult tetanus\u2013diphtheria\u2013acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink","volume":"27","author":"Yih","year":"2009","journal-title":"Vaccine"},{"issue":"68","key":"10.1016\/j.puhe.2015.03.003_bib11","first-page":"395","article-title":"An approach for assessing effectiveness of a vaccination campaign against pertussis among young adults: the example of the French armed forces","volume":"2014","author":"Sicard","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.puhe.2015.03.003_bib12","unstructured":"Haut conseil de la sant\u00e9 publique. Avis relatif \u00e0 l\u2019utilisation du vaccin m\u00e9ningococcique t\u00e9travalent conjugu\u00e9 A, C, Y, W135 NIMENRIX\u00ae et \u00e0 la place respective des vaccins m\u00e9ningococciques t\u00e9travalents conjugu\u00e9s et non conjugu\u00e9s. https:\/\/www.mesvaccins.net\/textes\/hcspa20120712_meningonimenrix.pdf."},{"issue":"Suppl.","key":"10.1016\/j.puhe.2015.03.003_bib13","doi-asserted-by":"crossref","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","article-title":"Quadrivalent meningococcal conjugate vaccines","volume":"27","author":"Pace","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2015.03.003_bib14","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.vaccine.2011.03.043","article-title":"Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second part of life: an open, randomized controlled trial","volume":"29","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2015.03.003_bib15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.arcped.2005.09.017","article-title":"French paediatrician and general practitionner's survey about actual and future BCG use","volume":"12","author":"de la Rocque","year":"2005","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.puhe.2015.03.003_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.arcped.2009.10.025","article-title":"Vaccination practices following the end of BCG compulsory vaccination. A cross sectional survey of general practitioners and pediatricians","volume":"17","author":"Wattrelot","year":"2010","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.puhe.2015.03.003_bib17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2015.03.003_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.puhe.2015.03.003_bib19","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.puhe.2015.03.003_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jadohealth.2012.07.017","article-title":"Use of MenACWY-CRM in adolescents in the United States","volume":"52","author":"Black","year":"2013","journal-title":"J Adolesc Health"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350615001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350615001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:24:34Z","timestamp":1651735474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350615001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0033350615001110"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2015.03.003","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of adverse events following vaccination in the French armed forces, 2011\u20132012","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}